These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 12938153)

  • 1. Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells.
    Markle RA; Han J; Summers BD; Yokoyama T; Hajjar KA; Hajjar DP; Gotto AM; Nicholson AC
    J Cell Biochem; 2003 Sep; 90(1):23-32. PubMed ID: 12938153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycation amplifies lipoprotein(a)-induced alterations in the generation of fibrinolytic regulators from human vascular endothelial cells.
    Zhang J; Ren S; Shen GX
    Atherosclerosis; 2000 Jun; 150(2):299-308. PubMed ID: 10856522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of rosuvastatin on fibrinolytic system of human umbilical vein endothelial cells in vitro.
    He F; Zhao J; Guo R; Liang Y
    Am J Med Sci; 2014 Oct; 348(4):319-23. PubMed ID: 24694789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.
    Louise CB; Obrig TG
    Microvasc Res; 1994 May; 47(3):377-87. PubMed ID: 8084301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells.
    Haslinger B; Kleemann R; Toet KH; Kooistra T
    Kidney Int; 2003 Jun; 63(6):2065-74. PubMed ID: 12753293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.
    Wiesbauer F; Kaun C; Zorn G; Maurer G; Huber K; Wojta J
    Br J Pharmacol; 2002 Jan; 135(1):284-92. PubMed ID: 11786505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells.
    Mussoni L; Banfi C; Sironi L; Arpaia M; Tremoli E
    Thromb Haemost; 2000 Jul; 84(1):59-64. PubMed ID: 10928471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering.
    Haslinger B; Goedde MF; Toet KH; Kooistra T
    Kidney Int; 2002 Nov; 62(5):1611-9. PubMed ID: 12371961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators.
    Sitter T; Toet K; Fricke H; Schiffl H; Held E; Kooistra T
    Am J Physiol; 1996 Nov; 271(5 Pt 2):R1256-63. PubMed ID: 8945961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro- and antifibrinolytic properties of human pulmonary microvascular versus artery endothelial cells: impact of endotoxin and tumor necrosis factor-alpha.
    Muth H; Maus U; Wygrecka M; Lohmeyer J; Grimminger F; Seeger W; Günther A
    Crit Care Med; 2004 Jan; 32(1):217-26. PubMed ID: 14707582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anisodamine counteracts lipopolysaccharide-induced tissue factor and plasminogen activator inhibitor-1 expression in human endothelial cells: contribution of the NF-kappa b pathway.
    Ruan QR; Zhang WJ; Hufnagl P; Kaun C; Binder BR; Wojta J
    J Vasc Res; 2001; 38(1):13-9. PubMed ID: 11173990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifibrinolytic properties of the vascular wall. Dependence on the history of smooth muscle cell doublings in vitro and in vivo.
    Christ G; Hufnagl P; Kaun C; Mundigler G; Laufer G; Huber K; Wojta J; Binder BR
    Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):723-30. PubMed ID: 9108786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fibrin on the secretion of plasminogen activator inhibitor-1 from endothelial cells and on protein kinase C.
    Fukao H; Matsumoto H; Ueshima S; Okada K; Matsuo O
    Life Sci; 1995; 57(13):1267-76. PubMed ID: 7674818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of plasminogen activator inhibitor 1 release by fibrin from human umbilical vein endothelial cells.
    Fukao H; Ueshima S; Tanaka N; Okada K; Matsuo O
    Thromb Res Suppl; 1990; 10():11-20. PubMed ID: 2107596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in culture.
    Pandolfi A; Iacoviello L; Capani F; Vitacolonna E; Donati MB; Consoli A
    Diabetologia; 1996 Dec; 39(12):1425-31. PubMed ID: 8960822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphasic regulation of plasminogen activator/inhibitor by LDL in mesangial cells.
    Song CY; Kim BC; Hong HK; Kim BK; Kim YS; Lee HS
    Am J Physiol Renal Physiol; 2002 Sep; 283(3):F423-30. PubMed ID: 12167592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: astragaloside IV downregulates plasminogen activator inhibitor-1 and upregulates tissue-type plasminogen activator expression.
    Zhang WJ; Wojta J; Binder BR
    J Vasc Res; 1997; 34(4):273-80. PubMed ID: 9256087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
    Orbe J; Chordá C; Montes R; Páramo JA
    Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium regulation of tissue plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells.
    Yamamoto C; Kaji T; Sakamoto M; Kozuka H; Koizumi F
    Thromb Res; 1994 Apr; 74(2):163-8. PubMed ID: 8029817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced tissue factor activity and plasminogen activator inhibitor-1 antigen in human umbilical vein endothelial cells incubated with lipoproteins.
    Kaneko T; Wada H; Wakita Y; Minamikawa K; Nakase T; Mori Y; Deguchi K; Shirakawa S
    Blood Coagul Fibrinolysis; 1994 Jun; 5(3):385-92. PubMed ID: 8075310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.